- Home
- / Ultimovacs
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Ultimovacs financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| NOK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53.0K | |||||||
| Gross profit | 53.0K | |||||||
| Gross profit margin, % | 100.0% | |||||||
| Operating expense total | 55.9M | 64.2M | 121.4M | 161.1M | 181.0M | 213.0M | 105.8M | 133.5M |
| Depreciation and amortization | 601.0K | 2.1M | 2.7M | 2.7M | 2.6M | 2.8M | 3.8M | 10.4M |
| EBITDA | (55.9M) | (64.2M) | (121.4M) | (161.1M) | (181.0M) | (213.0M) | (105.7M) | (133.4M) |
| EBITDA margin, % | -199484.9% | |||||||
| EBIT | (56.5M) | (66.2M) | (124.1M) | (163.8M) | (183.6M) | (215.7M) | (109.6M) | (143.8M) |
| EBIT margin, % | -206739.6% | |||||||
| Interest income | 1.3M | 5.5M | 4.6M | 3.1M | 8.9M | 14.1M | 3.0M | 3.6M |
| Interest expense | 133.0K | 263.0K | 240.0K | 334.0K | 243.0K | 382.0K | 38.0K | 105.0K |
| Pre tax profit | (55.3M) | (61.2M) | (120.6M) | (164.7M) | (167.8M) | (189.2M) | (105.2M) | (140.7M) |
| Net Income | (55.3M) | (61.2M) | (120.6M) | (164.7M) | (167.8M) | (189.2M) | (105.2M) | (140.7M) |